Skip to main content
Clinical Trials/NCT04401280
NCT04401280
Completed
Phase 3

Effectiveness of Novel Bioactive Glass in the Treatment of Enamel White Spot Lesions : A Randomized Controlled Trial

Rania Salah1 site in 1 country60 target enrollmentJune 1, 2020

Overview

Phase
Phase 3
Intervention
BiominF
Conditions
White Spot Lesion of Tooth
Sponsor
Rania Salah
Enrollment
60
Locations
1
Primary Endpoint
Change in White spot lesions dimension
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

the aim of this study is to evaluate the effectiveness of BiominF® and Novamin® in comparison to Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) in the treatment of enamel white spot lesions

Registry
clinicaltrials.gov
Start Date
June 1, 2020
End Date
June 30, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Rania Salah
Responsible Party
Sponsor Investigator
Principal Investigator

Rania Salah

Clinical instructor and Principal investigator at conservative dentistry department

Alexandria University

Eligibility Criteria

Inclusion Criteria

  • Not less than 1 white spot lesion on the labial surface of teeth in the anterior region with code 2 International Caries Detection and Assessment System II (ICDAS-II) or less
  • Absence of any active periodontal disease.
  • Written informed consent

Exclusion Criteria

  • Known hypersensitivity/allergy to study products and/or materials used
  • teeth having deep carious lesions or extensive restorations
  • Unwillingness to be randomly assigned to 1 of the 3 treatment groups
  • Advanced periodontal disease.

Arms & Interventions

BiominF®

Test group

Intervention: BiominF

Novamin®

Test group

Intervention: Novamin

CPP-ACP

Control group

Intervention: CPP-ACP

Outcomes

Primary Outcomes

Change in White spot lesions dimension

Time Frame: 6 months: (Baseline, 1 week, 1 month, 3 months, 6 months)

Quantified using computer-assisted analysis based on digital intraoral photographs

Secondary Outcomes

  • change in lesion fluorescence(6 months: (Baseline, 1 week, 1 month, 3 months, 6 months))

Study Sites (1)

Loading locations...

Similar Trials